8.2 Quantitative Blood Loss (QBL), PPH Staging & Pharmacologic/Surgical Protocols

8.2 Quantitative Blood Loss (QBL), PPH Staging & Pharmacologic/Surgical Protocols

Core Focus: Maternal-newborn nurses must expertly implement gravimetric and volumetric Quantitative Blood Loss (QBL) protocols, operationalize the standardized 4-stage obstetric hemorrhage escalation pathway, and master the comprehensive obstetric uterotonic pharmacopeia—with strict attention to drug-specific contraindications (e.g., Methergine in hypertension, Hemabate in asthma) and mechanical-surgical interventions.

---

1. Quantitative Blood Loss (QBL) vs. Estimated Blood Loss (EBL)

For decades, clinicians relied upon visual Estimated Blood Loss (EBL). Extensive clinical trials demonstrate that visual estimation is profoundly inaccurate, underestimating actual obstetric hemorrhage volume by 30% to 50%, with the degree of error increasing as blood loss accelerates. Underestimation breeds clinical complacency, delaying life-saving resuscitation until maternal decompensation is advanced.

Quantitative Blood Loss (QBL) is the objective, systematic measurement of cumulative blood loss using validated gravimetric and volumetric tools.

Core QBL Methodology

1. Gravimetric Measurement (Weighing Materials):
   • All blood-soaked sponges, laparotomy pads, chux pads, and peripads are weighed immediately upon removal from the field.
   • Mathematical Equivalence: 1 gram of weight = 1 milliliter (mL) of blood.
   • Standardized formula: $\text{Total Wet Weight (grams)} - \text{Known Dry Weight (grams)} = \text{Net Blood Loss (mL)}$
   • Dry weight reference cards must be posted on all delivery scales and resuscitation carts (e.g., dry dry-lap pad = 20 g; dry standard chux = 50 g; dry peri-pad = 15 g).
2. Volumetric Measurement (Calibrated Receptacles):
   • Deploy specialized under-buttocks collection drapes with calibrated, conical fluid pouches immediately following the birth of the infant.
   • Utilize dedicated wall suction canisters to collect blood during operative deliveries, systematically subtracting the known volumes of amniotic fluid suctioned prior to delivery and irrigation fluids instilled by the surgical team.

QBL Workflow Rule:
Initiate QBL immediately following infant birth (prior to placental delivery).
Record amniotic fluid volume prior to placental separation to establish a clean zero-baseline.

---

2. Staged Postpartum Hemorrhage Response

Hospitals use a staged pathway so recognition, medication, blood-bank communication, escalation, and operating-room readiness occur reliably. The stage names and numeric triggers vary by protocol. On the exam, use any supplied protocol; in practice, do not delay action because the blood-loss total has not crossed a memorized stage cutoff.

Immediate response to ongoing bleeding

1. Call for assistance and assess airway, breathing, circulation, mental status, skin perfusion, and bleeding source.
2. Quantify cumulative loss and trend vital signs. A smaller loss with shock signs is an emergency.
3. If the uterus is boggy, perform controlled fundal massage while supporting the lower segment, empty the bladder, and administer oxytocin under the pathway.
4. Assess the 4 Ts—Tone, Trauma, Tissue, and Thrombin—and treat the identified cause rather than assuming all bleeding is atony.
5. Establish/confirm large-bore access, draw CBC, coagulation studies and fibrinogen, warm the patient and fluids, and notify the blood bank when escalation is plausible.
6. Add cause- and contraindication-aware uterotonics, give tranexamic acid within the recommended window, and move promptly to tamponade, interventional radiology, or surgery when medication is insufficient.

Major hemorrhage and transfusion

Activate the institution’s massive-transfusion protocol for severe ongoing loss, shock, coagulopathy, or anticipated rapid product need. Balanced component delivery is common, but a fixed 1:1:1 ratio is not universal in obstetrics. Follow the local pack and use clinical response, fibrinogen, coagulation tests, platelet count, and viscoelastic testing when available. Pregnancy begins with high fibrinogen, so a falling or low value can be an early marker of severe hemorrhage. Prevent the lethal triad of hypothermia, acidosis, and coagulopathy and monitor ionized calcium during major transfusion.

Reassess after every intervention: uterine tone and position, genital-tract bleeding, cumulative loss, perfusion, urine output, laboratory trend, medication contraindications, and whether definitive source control is occurring.

3. Comprehensive Uterotonic & Antifibrinolytic Pharmacopeia

Maternal-newborn nurses must demonstrate fluency in the specific dosages, routes, administration constraints, and absolute contraindications of all second-line uterotonic agents:

[!CAUTION] THE EXAM TRAPS FOR UTEROTONICS:

• Client with High Blood Pressure / Preeclampsia: Methergine is strictly contraindicated. Administer Hemabate, Misoprostol, or TXA.
• Client with Asthma / Wheezing / Reactive Airway Disease: Hemabate is strictly contraindicated. Administer Methergine (if normotensive), Misoprostol, or TXA.
• Client with BOTH Hypertension AND Asthma: Both Methergine and Hemabate are contraindicated! Administer Misoprostol sublingually/rectally and Tranexamic Acid (TXA) IV.

The Landmark WOMAN Trial & Tranexamic Acid (TXA)

The World Maternal Antifibrinolytic (WOMAN) trial (over 20,000 enrolled women) proved that administering 1 g of IV TXA within 3 hours of birth reduced maternal deaths due to bleeding by nearly one-third without increasing thromboembolic complications. TXA competitively blocks lysine-binding sites on plasminogen, halting its conversion into plasmin and preventing the enzymatic breakdown of fibrin clots.

---

4. Mechanical, Interventional & Surgical Management

When pharmacologic therapies fail to arrest hemorrhage, mechanical and surgical interventions are deployed immediately:

Surgical Escalation Ladder:
Intrauterine Balloon Tamponade (Bakri) ──> Uterine Compression Sutures (B-Lynch)
──> Pelvic Arterial Ligation / Embolization ──> Emergent Peripartum Hysterectomy

1. Intrauterine Balloon Tamponade (Bakri Balloon)

• Mechanism: A 24-French silicone balloon catheter is inserted transvaginally into the uterine cavity under ultrasound guidance and inflated with 300 to 500 mL of sterile saline (never air or sterile water). The inflated balloon exerts uniform inward hydrostatic pressure against the bleeding endometrial venous sinuses and placental site.
• The "Tamponade Test": The catheter features a central drainage lumen connected to a collection bag. If bleeding through the lumen and around the balloon drops to <50 mL within 15 to 30 minutes, the test is positive. The balloon is left in place for 12 to 24 hours under prophylactic antibiotic coverage and low-dose oxytocin infusion to maintain myometrial compression. If heavy bleeding persists, the test is negative, and the patient must immediately proceed to laparotomy.

2. Uterine Compression Sutures (B-Lynch Technique)

• Deployed during exploratory laparotomy. Absorbable suture material is looped vertically over the fundus from anterior to posterior (like suspenders), physically compressing the anterior and posterior myometrial walls together to achieve mechanical tamponade while preserving future fertility.

3. Pelvic Arterial Ligation & Uterine Artery Embolization (UAE)

• Surgical Ligation: Bilateral surgical ligation of the ascending uterine arteries or internal iliac (hypogastric) arteries reduces pelvic pulse pressure by approximately 85%, allowing local clotting cascades to achieve hemostasis.
• Uterine Artery Embolization (UAE): Performed in interventional radiology for hemodynamically stable patients. Catheters deliver absorbable gelatin sponge particles (Gelfoam) to occlude bilateral uterine arteries, arresting flow while collateral vessels preserve tissue viability.

4. Emergent Peripartum Hysterectomy

• The definitive, life-saving end-stage procedure when all conservative medical, mechanical, and surgical therapies have failed. Indicated for uncontainable hemorrhage, massive uterine rupture, or advanced placenta percreta.